Don’t Derail Drug Development: 5 Common Issues to Identify and Avoid With a First-Rate Quality Process

Learn the importance of Quality and when to bring an expert into your drug development process.

Register Free: https://www.pharmtech.com/pt_w/first-rate

Event Overview:

Quality encompasses adherence to regulatory compliance, which includes ensuring the safety and efficacy of pharmaceutical supplies, product development, and regulatory improvement, and maintaining an uninterrupted supply chain. In this webcast, Syner-G BioPharma Group’s Director of Quality Assurance and Compliance, Bryan Abney, will discuss the importance of identifying the most common issues that can derail drug development and will advise on how to avoid them while implementing and maintaining excellent Quality processes.

Key Learning Objectives:

Attendees will learn:

• The consequences of a derailed drug development program
• The top 5 issues to be avoided
• The importance and benefits of a strong Quality culture
• Why a company should consider partnering with consulting experts and when to seek support

Featured Speakers:

Bryan Abney
Vice President of Quality Assurance
and Compliance
Syner-G BioPharma Group

Bryan Abney is the Vice President of Quality Assurance and Compliance and a member of the Syner-G team since March 2022. He is an experienced pharmaceutical Quality professional with 30 years of progressive experience directing quality control, analytical development and validation, product/process remediation, and quality assurance. His specialties include Analytical Chemistry, ICH and FDA guidelines, ANDA, and NDA. His main area of expertise is in Quality Management Systems.

Katie W. Winder
Associate Director Quality and
Compliance
Syner-G BioPharma Group

Katie W. Winder is the Associate Director of Quality and Compliance and has been a leader in the pharmaceutical cGMP environment for the past 17 years, helping to oversee responsibilities supporting Quality Assurance and Quality Control. Her responsibilities have included providing phase appropriate implementation or improvement in Quality Systems and guidance in decision making for Quality problems ranging by complexity to the industry based on her experience.

Register Free: https://www.pharmtech.com/pt_w/first-rate